Eta Diagnostics, Inc. (ETAD) is a pre-revenue startup devoted to the development and commercialization of high throughput “massively parallel” flow cytometry. Using patented and patent-pending acoustic and optical technologies licensed from the University of New Mexico’s Center for Biomedical Engineering (UNM/CBME), the Company is targeting very high volumetric flow rate (50 mL per minute) applications, many of which require detection rates of one million events per second or higher. Examples of such applications include in-line sterility monitoring in pharmaceutical manufacturing and beverage production, waste water treatment, the detection of bladder cancer cells in urine, and the counting and analysis of rare Circulating Tumor Cells (CTCs) in human blood.